Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
AKTIENPREIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionCerity Partners LLC
Latest Disclosed Ownership161,430 shares
Latest Disclosed Value $ 7,743,773
Cerity Partners LLC reports 39.89% increase in ownership of RPD / Royalty Pharma plc

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 161,430 shares of Royalty Pharma plc (DE:RPD) valued at $6,468,500 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 115,395 shares of Royalty Pharma plc. This represents a change in shares of 39.89% during the quarter. The current value of the position is $7,575,103 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 161,430 46,035 39.89 7,744 73.69 0.0054
2026-02-11 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 115,395 34,420 42.51 4,459 56.09 0.0065
2025-10-22 2025-09-30 13F ROYALTY PHARMA COM G7709Q104 80,975 -75,555 -48.27 2,857 -49.35 0.0046
2025-08-13 2025-06-30 13F ROYALTY PHARMA Stock G7709Q104 156,530 2,684 1.74 5,640 17.75 0.0101
2025-04-30 2025-03-31 13F ROYALTY PHARMA Stock G7709Q104 153,846 136,487 786.26 4,789 943.36 0.0097
2025-02-13 2024-12-31 13F ROYALTY PHARMA COM G7709Q104 17,359 -15,537 -47.23 459 -50.65 0.0010
2024-11-12 2024-09-30 13F ROYALTY PHARMA Stock G7709Q104 32,896 3,291 11.12 931 19.23 0.0021
2024-08-13 2024-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 29,605 -6,822 -18.73 781 -29.48 0.0021
2024-05-14 2024-03-31 13F ROYALTY PHARMA Stock G7709Q104 36,427 8,259 29.32 1,106 39.82 0.0029
2024-01-26 2023-12-31 13F ROYALTY PHARMA Stock G7709Q104 28,168 28,168 791 0.0026
2023-11-14 2023-09-30 13F ROYALTY PHARMA COM G7709Q104 0 -25,788 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ROYALTY PHARMA COM G7709Q104 25,788 943 3.80 793 -11.31 0.0031
2023-05-11 2023-03-31 13F ROYALTY PHARMA COM G7709Q104 24,845 689 2.85 893 -6.39 0.0021
2023-02-15 2022-12-31 13F ROYALTY PHARMA Stock G7709Q104 24,156 177 0.74 954 -0.93 0.0061
2022-11-14 2022-09-30 13F ROYALTY PHARMA Stock G7709Q104 23,979 520 2.22 963 -2.43 0.0116
2022-08-10 2022-06-30 13F ROYALTY PHARMA COM G7709Q104 23,459 2,567 12.29 987 21.40 0.0109
2022-04-25 2022-03-31 13F ROYALTY PHARMA COM G7709Q104 20,892 20,892 813 0.0126
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.